Article
Oncology
Tara Behroozian, Lauren Milton, Irene Karam, Liying Zhang, Keyue Ding, Julia Lou, Francois Gallant, Eileen Rakovitch, William Tran, Hany Soliman, Eric Leung, Danny Vesprini, Ewa Szumacher, Hanbo Chen, Elysia Donovan, Jacqueline Lam, Silvana Spadafora, Matt Wronski, Chris Lavoie, Natalie Walde, Emily Lam, Gina Wong, Erin McKenzie, Krista Ariello, Samantha Kennedy, Saba Shariati, Katherine Carothers, Glen Gonzales, Yulya Kagan, Edward Chow
Summary: A confirmatory randomized controlled trial was conducted to evaluate the effectiveness of Mepitel film (MF) in reducing radiation dermatitis (RD) in patients undergoing breast radiotherapy. The results showed that MF significantly reduced the incidence of grade 2 or 3 RD and had positive effects on patient-reported outcomes and clinician-reported outcomes.
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Endocrinology & Metabolism
Dennis Zetner, Claus Kamby, Camilla Christophersen, Sengul Gulen, Cecilie B. Paulsen, Emily Piga, Bodil Hoffmeyer, Faisal Mahmood, Jacob Rosenberg
Summary: This double-blind, placebo-controlled randomized study investigated whether melatonin can protect against radiation dermatitis in women receiving radiation therapy for primary breast cancer. The results showed no difference in RTOG-scores and pixel analyses at 2 weeks follow-up between the melatonin and placebo groups. However, the melatonin group demonstrated a protective effect based on RTOG-scores over the entire duration of the study.
JOURNAL OF PINEAL RESEARCH
(2023)
Article
Oncology
Yuxiu Xie, Ting Hu, Renwang Chen, Haiyan Chang, Qiong Wang, Jing Cheng
Summary: Individualized risk assessments of breast cancer patients receiving radiotherapy identified body mass index, diabetes, smoking history, higher ferritin, higher hs-CRP, and higher CD3 + T cells as independent risk factors for severe acute radiation dermatitis (ARD).
Article
Pharmacology & Pharmacy
Eun Hye Kim, Su Bin Park, Hayun Jin, Weon Kuu Chung, Seong Woo Yoon
Summary: This study aimed to evaluate the comparative efficacy and safety of Jaungo and the water-in-oil-type non-steroidal moisturizer for the prevention of radiation-induced dermatitis (RID) in breast cancer patients undergoing radiation therapy. The results showed that Jaungo and the moisturizer had similar preventive efficacy against RID and no severe side effects. Further large-scale randomized controlled trials are needed to validate these findings.
FRONTIERS IN PHARMACOLOGY
(2023)
Review
Oncology
Yuxiu Xie, Qiong Wang, Ting Hu, Renwang Chen, Jue Wang, Haiyan Chang, Jing Cheng
Summary: This study analyzed 38 studies involving 15,623 breast cancer patients and found that high body mass index, large breast volume, smoking, and diabetes were significant patient-related risk factors for ARD. Hypofractionated radiotherapy was shown to reduce the risk of ARD, while factors such as boost administration were associated with an increased risk. Variations in study design, country, and toxicity evaluation scale may explain sources of heterogeneity.
FRONTIERS IN ONCOLOGY
(2021)
Article
Pharmacology & Pharmacy
Eun Hye Kim, Jee-Hyun Yoon, Su Bin Park, Jee Young Lee, Weon Kuu Chung, Seong Woo Yoon
Summary: This study aims to evaluate the preventive efficacy of Jaungo compared to a non-steroidal moisturizer in reducing radiation-induced dermatitis in postoperative breast cancer patients undergoing radiation therapy. The trial is currently ongoing and will provide evidence for traditional Korean medicine clinical practice.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Oncology
Jolien Robijns, Leen Van Bever, Sanne Hermans, Marithe Claes, Joy Lodewijckx, Melissa Lenaerts, Laura Tuts, Eline Vandaele, Evelien Vinken, Leen Noe, Katleen Verboven, Annelies Maes, Anne-Sophie van de Velde, Paul Bulens, Philippe Bulens, Laura van den Bergh, Jeroen Mebis
Summary: The study demonstrated that the novel multi-active emollient significantly reduced the severity of ARD according to RTOG grading. The impact on quality of life was minimal, and treatment satisfaction was high in both groups.
SUPPORTIVE CARE IN CANCER
(2023)
Review
Oncology
Kenji Sekiguchi, Minako Sumi, Anneyuko Saito, Sadamoto Zenda, Satoko Arahira, Keiko Iino, Masayuki Okumura, Fujimi Kawai, Keiko Nozawa
Summary: This study conducted a systematic review and meta-analysis to investigate the effectiveness of moisturizers on acute radiation dermatitis (ARD) in breast cancer patients receiving radiotherapy (RT). The findings suggest that the use of moisturizer may reduce the severity of ARD and improve skin-related quality of life (QOL).
Article
Oncology
Kuan Wu, Xiaoyan Miu, Hui Wang, Xiadong Li
Summary: The purpose of this study was to develop a Bayesian optimization based multi-stacking deep learning platform for the prediction of radiation-induced dermatitis (grade ≥2) before radiotherapy in breast cancer patients. The study used radiomics features extracted from pre-treatment planning 4D-CT images and clinical and dosimetric characteristics to train and validate the prediction model. The final model achieved high accuracy in predicting symptomatic radiation-induced dermatitis in breast cancer patients.
FRONTIERS IN ONCOLOGY
(2023)
Article
Oncology
Xiran Wang, Jianling Zhao, Zhongzheng Xiang, Xuetao Wang, Yuanyuan Zeng, Ting Luo, Xi Yan, Zhuang Zhang, Feng Wang, Lei Liu
Summary: In this study, the value of a 3D-printed bolus in postmastectomy chest wall radiation therapy for breast cancer was investigated. The results showed that the 3D-printed bolus could ensure precise radiation dose on the skin surface, good fitness to the skin, and controllable acute skin toxicity.
FRONTIERS IN ONCOLOGY
(2022)
Article
Endocrinology & Metabolism
Dennis Zetner, Claus Kamby, Sengul Gulen, Camilla Christophersen, Cecilie B. Paulsen, Emily Piga, Bodil Hoffmeyer, Faisal Mahmood, Jacob Rosenberg
Summary: This study aimed to investigate the impact of topical melatonin during radiation therapy on the quality of life in primary breast cancer patients. A total of 65 patients were included in the study, with 26 in the melatonin group and 22 in the placebo group. The results showed that while there was no difference in breast symptom scores on the last day of radiation, the melatonin group had significantly lower scores over the entire duration of the trial.
JOURNAL OF PINEAL RESEARCH
(2023)
Article
Oncology
Edwin A. Robledo, Juan Murillo, Raquel Veiga Martin, Kevin Leiva, Corina Beiner, Maria Amelia Rodrigues, Marcio Fagundes, Joseph Panoff, Michael Chuong, Wensong Wu, Anuradha Godavarty
Summary: This study aimed to explore the microvascular changes in tissue oxygenation in breast cancer patients undergoing radiation therapy (RT) using near-infrared spectroscopic imaging and correlate these changes to the grading of radiation dermatitis (RD). The results showed significant decreases in oxygen saturation in the irradiated regions during RT, which were negatively correlated with RD grading. Differences in pre-RT tissue oxygenation between the irradiated and contralateral regions could potentially predict the severity of RD.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Chin-Nan Chu, Kai-Chieh Hu, Rick Sai-Chuen Wu, Da-Tian Bau
Summary: This study found that breast cancer patients after whole breast radiotherapy may experience skin dryness, hypersensitivity, and hyperpigmentation in the irradiated skin area. These radiation-induced skin lesions could lead to depressive psychological status and impact the quality of life in breast cancer patients after whole breast radiotherapy.
Review
Oncology
Shing Fung Lee, Saba Shariati, Saverio Caini, Henry Wong, Adrian W. Chan, Milena Gojsevic, Mami Ogita, Jason C. Ye, David Chia, Michael Chao, KiHoon Sung, Samantha K. F. Kennedy, Thenugaa Rajeswaran, Corina van den Hurk, Julie Ryan Wolf, Raymond J. Chan, Tara Behroozian, Pierluigi Bonomo, Edward Chow
Summary: The purpose of this study was to evaluate the overall efficacy of StrataXRT in preventing acute radiation dermatitis in breast cancer patients undergoing radiotherapy. Based on the analysis of three randomized controlled trials, it was found that StrataXRT can effectively prevent acute radiation dermatitis without raising additional safety concerns. However, further high quality, large-scale studies are needed to confirm these findings.
SUPPORTIVE CARE IN CANCER
(2023)
Article
Oncology
Yana Kost, Alexandra K. Rzepecki, Alana Deutsch, Mathew R. Birnbaum, Nitin Ohri, H. Dean Hosgood, Juan Lin, Johanna P. Daily, Kosaku Shinoda, Beth N. McLellan
Summary: This prospective cohort study found that nasal colonization with Staphylococcus aureus (SA) before radiation therapy was associated with the development of grade 2 or higher acute radiation dermatitis (ARD) in patients with breast or head and neck cancer.